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Abstract: This study was conducted to determine the effects of subanesthetic doses of ketamine given prior to premedication on the
quality of anesthesia, recovery, and postoperative pain in horses. Eighteen horses were randomly recruited into three equal groups, S,
LK, and HK, wherein saline, ketamine at 0.2 mg/kg body weight (bwt), and ketamine at 0.4 mg/kg bwt were given, respectively, i.v. for 30
min as a continuous rate infusion (CRI). Horses were premedicated with xylazine at 1 mg/kg bwt i.v. and butorphanol at 0.05 mg/kg bwt
i.v. after 30 min. Anesthesia was induced using ketamine and midazolam and was maintained with ketamine at 2 mg/kg/h as CRI, and
bolus doses of thiopental 5% solution was given i.v. whenever necessary. Preemptive ketamine infusion clinically enhanced the quality
of sedation and enabled smooth induction with significantly (P < 0.05) higher sedation and postinfusion ataxia and shorter down-time
(P < 0.05) in group HK. Physiological, hematological, serological, and vital parameters remained within normal limits. All the horses
recovered well without any adverse effects and stood in less than 2 h after surgery. Fluctuation in pain scores at 1 h and 2 h after the end
of surgery was minimum in group HK.
Key words: Horse, general anesthesia, preemptive analgesia, subanesthetic dose, ketamine

1. Introduction
A balanced, multimodal approach to anesthesia and
analgesia has become the standard for quality patient care
in equine surgery. Ketamine is a potent noncompetitive
antagonist at N-methyl-D-aspartate (NMDA) receptors in
the spinal cord that are thought to be responsible for the
wind-up, i.e. an exaggerated painful response to relatively
innocuous stimuli following a primary injury, and hence
it is an effective analgesic (1). Ketamine may also produce
analgesia by interaction with opioid receptors in the
central nervous system (2). It also contributes to balanced
anesthesia by providing intrinsic analgesia during
surgery, reduces the drug requirements for maintenance,
and enhances recovery during the postoperative period
(3,4). Subanesthetic doses of ketamine have been used
to provide analgesia in awake and anesthetized horses
effectively (5) and to augment sedation along with xylazine
and butorphanol in standing anesthesia without any
adverse side effects (6). Studies investigating the use of a

subanesthetic dose of ketamine at 0.6 mg/kg/h have been
shown to enhance analgesia in chronic laminitis (7). Much
evidence was obtained from studies where subanesthetic
doses of ketamine at 0.8 mg/kg/h were administered in
awake horses for more than 6 h without any adverse effects,
suggesting that ketamine has marked safety for prolonged
infusion in awake horses (8,9). In addition to its analgesic
properties, ketamine is well documented to mitigate the
stress response to surgical procedures (10) and to have
antiinflammatory properties (11). Ketamine continuous
rate infusion (CRI) is administered as an adjunct to general
anesthesia to maintain and increase anesthetic depth (12).
Investigations on CRIs of ketamine in horses have shown
minimal cardiovascular depression, preserved laryngeal
protective reflexes, and maintained ventilation better than
many commonly employed anesthetic or analgesic agents
(13,14).
The hypothesis of this investigation was that
preoperative administration of subanesthetic doses of
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ketamine 30 min prior to premedication provides better
surgical analgesia, enhances sedation, and enables smooth
anesthetic induction. The aim of the study was to compare
the quality of sedation, quality of induction, quality of
surgical anesthesia, quality of anesthetic recovery, and
degree of postoperative pain experienced by horses
following the use of subanesthetic doses of ketamine as
an intravenous (i.v.) infusion administered nearly 30 min
before premedication in conventional clinical settings
for short- to medium-term surgical procedures. The
secondary aim was to evaluate any differences in surgical
stress and inflammation in addition to physiological
variables and other drug requirements during total i.v.
anesthesia (TIVA) in equines. To the best of the authors’
knowledge, studies on subanesthetic doses of ketamine as
an i.v. infusion given well before premedication along with
TIVA in horses have not been reported.
2. Materials and methods
The study was approved by the Committee for the
Purpose of Control and Supervision of Experiments on
Animals (CPCSEA), Ministry of Environment, Forest,
and Climate Change, Government of India, as per F. No.
25/33/2016-CPCSEA, and informed consent was obtained
from the owner of each horse before any drugs were given.
2.1. Horse details
Eighteen client-owned horses graded ASA 1 or 2 by the
physical status classification system of the American
Society of Anesthesiologists (15), weighing 265.83 ± 15.3
kg (mean ± SE) and belonging to either sex, referred for
surgical procedures requiring nearly 1 h were included in
the study. A power calculation was not carried out prior
to the start of the study because of limited preliminary
data on which such an analysis can rely. Moreover, data
collection was bound by the number of eligible horses
that were presented to the clinic during the period of the
study in order to make appropriate statistical comparisons
as horses with severe respiratory, renal, cardiac, or
gastrointestinal conditions; pregnancy or lactation; and
history of treatment with analgesics were excluded.
2.2. Preemptive ketamine infusion, premedication, and
induction
The selected 18 horses were randomly divided into three
groups, designated as group saline (S), low ketamine (LK),
and high ketamine (HK). The horses were restrained in
stocks before the start of any anesthetic administration.
The jugular area was clipped and shaved for the placement
of a catheter. Adequate time (3–4 h) was allowed for
acclimatization of the horse to the environment. Care
was taken to avoid noise disturbances during the entire
protocol. Body weight measurements were done using
a standard estimation formula: body weight (kg) =
[girth (cm)2 × length (cm)]/11877 (16). The animals

were evaluated by a thorough physical examination that
included heart rate (HR), respiratory rate (RR), rectal
temperature (RT), gut sounds, color of mucous membrane,
and capillary refill time (CRT), along with complete blood
count and serum biochemistry. The general behavior of
the horses was observed and initial overall pain score were
assessed, and the base values for different parameters were
recorded before any drugs were given.
In horses of groups LK and HK, preemptive i.v.
ketamine (Ketamax 50, Troikaa Pharmaceuticals Ltd.,
Dehradun, Uttarakhand, India) at 0.2 mg/kg body weight
(bwt) and 0.4 mg/kg bwt, respectively, was given along
with i.v. normal saline (NS, Nirma Limited, Gujarat, India)
for 30 min as a CRI through a 14-gauge jugular venous
catheter that was placed into the jugular vein along with a
three-way stopcock and fixed onto the neck using secure
tape. For the horses of group S, normal saline alone was
administered without adding the test drug. During and
after preemptive ketamine infusion, the animals were
continuously monitored for any abnormal behavior and
variations in routine clinical parameters. Ataxia after
cessation of preemptive ketamine infusion was scored as
1 (no ataxia), 2 (very mild, slight loss of balance when
turning, otherwise steady), 3 (mild, unstable when turning,
occasionally staggering when walking), 4 (moderate,
frequent staggering when walking, wide-base stance), 5
(moderately severe, needs assistance to prevent falling), or
6 (severe, falls despite assistance) (17). All the assessments
and observations were performed by a single blinded
observer throughout the study. The observer was unaware
of the protocol on subanesthetic doses of ketamine used in
each case. Blinding was made complete as ketamine was
administered as an i.v. infusion mixed along with normal
saline solution.
Thirty minutes after the cessation of infusion (lag
period), the animals were administered an alpha2
adrenoceptor agonist, xylazine (Xylaxin, Stanex Drugs
and Chemicals Pvt. Ltd., Hyderabad, Andhra Pradesh,
India), at 1 mg/kg bwt, i.v., immediately followed by an
opioid, butorphanol (Butodol-2, Neon Laboratories
Limited, Mumbai, Maharashtra, India), at 0.05 mg/kg bwt,
i.v., through the jugular venous catheter using separate
syringes. After administration of preanesthetic drugs,
horses were left calm to allow the onset of effects of the
drugs. Quality of sedation after premedication was scored
as 1 (calm, relaxed, no restraint required, minimally
responsive to environmental stimuli, reluctant to move),
2 (no restraint required, relaxed, infrequent responses to
environmental stimuli, easily walked without problems),
3 (minimal restraint required, interested in environmental
stimuli, reactive to noise and sudden movements),
or 4 (unsatisfactory, minimal or no signs of sedation,
nervousness or apprehension requiring additional sedative
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administration) (18). Down-time (min) was recorded in
preemptive ketamine-infused horses as the time from the
preanesthetic drug administration until the horse achieved
recumbency. The recumbent animals were secured on the
operating table.
Anesthesia was induced using ketamine at 2 mg/kg bwt
and midazolam (Mezolam, VHB Medi Sciences Limited,
Pantnagar, Uttarakhand, India) at 0.2 mg/kg bwt, i.v.,
administrated through the catheter. Induction was done
in horses infused with preemptive ketamine immediately
after recumbency and after 10 min of premedication
in the control group. Quality of induction was scored
as 1 (minimal or no muscle twitching, no movement,
relaxed limbs), 2 (brief muscle rigidity followed by
relaxation and minimal movement), 3 (marked muscle
rigidity, movement, struggling), or 4 (fails to attain lateral
recumbency) (18).
2.3. Maintenance of anesthesia
Anesthesia was maintained with i.v. ketamine at 2 mg/
kg/h as a CRI. After induction, all horses were intubated
and allowed to breathe spontaneously. An endotracheal
tube was secured for administration of oxygen and to
shift to inhalant anesthetic maintenance using volatile
agents whenever necessary, particularly if the surgical
procedure considerably exceeded more than 1 h. Bolus
doses of i.v. thiopental (thiosol sodium) 5% solution
were administered whenever an inadequacy in surgical
anesthesia was observed.
Surgery was carried out according to the routine
protocol of the clinic. Routine monitoring included HR,
RR, RT, color of mucous membrane, gut movements, CRT,
noninvasive mean arterial blood pressure (MABP), and
peripheral oxygen saturation (SPO2) (Globalvets 5000,
Global Technology Solutions LLC, New Delhi, India),
measured using appropriate instruments. Quality of
surgical anesthesia was recorded as the average of the scores
of degree of muscle relaxation and quality of analgesia and
was scored by the same surgeon for all the horses, unaware
of treatment allocation. Degree of muscle relaxation was
scored as 1 (no trunk or limb twitching or movement,
no resistance to flexion of limbs), 2 (slight trunk or limb
muscle twitching, minimal resistance to flexion of limbs),
3 (strong trunk or limb muscle twitching, resistance
to flexion of limbs), or 4 (muscle rigidity and strong
resistance to flexion of limbs) (18). Quality of analgesia
(i.e. response to surgical stimulation) was scored as 1 (no
response to surgical stimulation), 2 (brief contraction
of abdominal or limb muscles, temporary twitching or
spasms), 3 (movement of a fore limb or hind limb), or 4
(repeated movement of a fore limb or hind limb requiring
additional drug administration) (18). The total dose of
thiopental used for maintenance of anesthesia (mg) and
the duration of surgical procedure (min) were recorded.
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Local anesthetics and analgesics such as opioids, alpha2
adrenergic receptor agonists, beta1-adrenergic receptor
agonists, steroids, and nonsteroidal antiinflammatory
drugs (NSAIDs) were not used perioperatively or up to 2
h after surgery.
2.4. Postoperative period and recovery
After surgery, horses were allowed to recover in a padded
recovery box under observation and manual assistance
was given if necessary. Upon completion of surgery and
discontinuation of anesthesia, the time to first head lift
(min), time to sternal recumbency (min), and standing
time (min) were recorded. The time to first head lift is
the time from the discontinuation of anesthesia until first
lifting of head. The time to sternal recumbency is the time
from the discontinuation of anesthesia until the animal
moves to sternal recumbency and the standing time is
the time from the discontinuation of anesthesia until the
animal is able to stand steadily. Quality of recovery from
anesthesia was scored as 1 (unassisted, uneventful, 1
attempt to stand), 2 (unassisted, 2 or 3 attempts to stand),
3 (minimal assistance requiring 1 attendant because of
>3 attempts to stand), or 4 (assistance to stand requiring
2 attendants to provide head and tail support because
of moderate or severe ataxia) (18). Postoperative ataxia
was scored as performed for scoring ataxia following the
infusion of preemptive ketamine (4).
2.5. Hematological and serum biochemical observations
Routine monitoring of hematological and serological
parameters, including hemoglobin (Hb), packed cell
volume (PCV), differential leukocyte count (DLC),
and total leukocyte count (TLC), was performed using
appropriate equipment. Blood glucose estimations were
done using a ROMOCHECK glucometer (Romsons
Scientific & Surgical Pvt. Ltd., Nunhai, Agra, Uttar
Pradesh, India). Serum biochemistry parameters, aspartate
aminotransferase (AST), alanine aminotransferase (ALT),
blood urea nitrogen (BUN), creatinine, cholesterol, and
triglycerides were measured using appropriate diagnostic
kits (Coral Clinical Systems, Bambolim Complex P. O.,
Goa, India) via spectrophotometric methods. Serum
insulin, cortisol, and interleukin-6 (IL-6) were measured
using horse-specific ELISA kits (BlueGene Biotech, Putuo,
Shanghai, China).
Clinical, physiological, hematological, and serological
parameters were monitored and recorded before drug
administration (base value), at the point of anesthetic
induction (0), and at 30, 60, 120, and 180 min after
anesthetic induction.
2.6. zOverall pain score
The overall pain score was evaluated according to the
composite pain score based on the parameters contributing
to the behavior of the animal, response to observer, and
physiological parameters (Table 1) (19). These parameters
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Table 1. Multifactorial numerical rating composite pain scale used to score pain.

Response to observer

Behavior of animal

Parameters

Scores and description

Appearance

1. Bright, lowered head and ears, no reluctance to move
2. Bright and alert, occasional head movements, no reluctance to move
3. Restlessness, pricked up ears, abnormal facial expressions, dilated pupils
4. Excited, continuous body movements, abnormal facial expression

Sweating

1. No obvious signs of sweat
2. Damp to the touch
3. Wet to the touch, beads of sweat apparent over the horse’s body
4. Excessive sweating, beads of water running off the animal

Kicking at
abdomen

1. Quietly standing, no kicking
2. Occasional kicking at abdomen (1–2 times/5 min)
3. Frequent kicking at abdomen (3–4 times/5 min)
4. Excessive kicking at abdomen (>5 times/5 min), intermittent attempts to lie down and roll

Pawing on
floor

1. Quietly standing, no pawing
2. Occasional pawing (1–2 times/5 min)
3. Frequent pawing (3–4 times/5 min)
4. Excessive pawing (>5 times/5 min)

Posture

1. Stands quietly, normal walk
2. Occasional weight shift, slight muscle tremors
3. Non-weight-bearing, abnormal weight distribution
4. Analgesic posture (attempts to urinate), prostration, muscle tremors

Head
movements

1. No evidence of discomfort, head straight ahead for the most part
2. Intermittent head movements laterally or vertically, looking at flanks (1–2/5 min), lip curling (1–2/5 min)
3. Intermittent and rapid head movements laterally or vertically, frequent looking at flanks (3–4/5 min), lip
curling (3–4/5 min)
4. Continuous head movements, excessively looking at flanks (>5 times/5 min), lip curling (>5 times/5 min)

Appetite

1. Eats hay readily or is not allowed to eat hay
2. Hesitates to eat hay
3. Shows little interest in hay, eats very little or takes hay into mouth but does not chew or swallow
4. Neither shows interest in nor eats hay

Interactive
behavior

1. Pays attention to people
2. Exaggerated response to auditory stimulus
3. Excessive to aggressive response to auditory stimulus
4. Stupor, prostration, no response to auditory stimulus

Response to
palpation of the
painful area

1. No reaction to palpation
2. Mild reaction to palpation
3. Resistance to palpation
4. Violent reaction to palpation
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Physiological data

Table 1. (Continued).

Heart rate

1. 24–44 bpm
2. 45–52 bpm
3. 53–60 bpm
4. >60 bpm

Respiratory rate

1. 8–13 breaths pm
2. 14–16 breaths pm
3. 17–18 breaths pm
4. >18 breaths pm

Rectal
temperature

1. 36.98–38.58 °C
2. 36.48–36.98 °C or 38.58–39.08 °C
3. 35.98–36.48 °C or 39.08–39.58 °C
4. 35.48–35.98 °C or 39.58–40.08 °C

Digestive
sounds (bowel
movements)

1. Normal motility
2. Decreased motility
3. No motility
4. Hypermotility

were recorded in all horses before any drugs were given
(base value), at 120 min (1 h after the end of surgery), and
at 180 min (2 h after the end of surgery). The cumulative
score was obtained by adding individual observations
with a range of 13–52. Additional analgesics, NSAIDs, or
other treatments were given 2 h after the end of surgery as
deemed appropriate by the clinician. Any adverse events
were also documented.
2.7. Data analysis
All statistical analysis was performed using the statistical
software package SAS 9.3. The data from horses in the LK
and HK groups were compared with those in group S. The
primary outcome of the study was to measure the quality
of sedation, down-time, quality of analgesia, and quality
of anesthetic induction with a null hypothesis that there
would be no differences between the groups. Secondary
outcome measures were physiological variables, quality of
recovery, and degree of postoperative pain and ataxia with
a null hypothesis of no differences between the groups.
Single measurements of continuous variables between
groups were compared using one-way analysis of variance
(ANOVA). Continuous data of parametric variables within
and between groups collected at different time intervals
were analyzed using repeated measures ANOVA. For
both one-way ANOVA and repeated measures ANOVA,
the post hoc Tukey HSD test was employed. Nonnormally
distributed data or nonparametric variables (scores) at
different intervals were compared using the Kruskal–
Wallis test. Dunn’s test was used for analyzing pairwise
differences in groups if there was a tied rank for the
Kruskal–Wallis test (20).
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3. Results
3.1. Horse details
Eighteen horses admitted for short- to medium-term
surgical procedures were randomly divided into three
groups (Table 2). There was no significant difference
between groups with regard to body weight or age (P >
0.05).
3.2. Preemptive ketamine infusion, premedication, and
induction
During and after preemptive ketamine infusion, frequent
shifting of weight in limbs was evident in ketamine-infused
horses and its frequency was slightly higher in group HK.
Ataxia was found to be significantly higher (P < 0.05) in
group HK than in group S (Table 3) during the lag period.
The mucous membrane was pale pink in all horses. HR,
RR, and RT did not show much deviation from base values
during i.v. ketamine infusion or during the lag period
(Figure 1).
All horses were visibly sedated after the preanesthetics
were given immediately prior to induction. Clinically,
sedation was better among horses that received
subanesthetic doses of the preemptive ketamine infusions
compared to group S, with the most significant (P < 0.05)
sedation scores in the HK group (Table 3). The mean downtime in preemptive ketamine-infused horses in groups HK
and LK were 2 ± 0.32 min and 5 ± 0.32 min, respectively.
A dose-dependent significantly shorter down-time (P <
0.05) was noticed between groups LK and HK. Anesthesia
was induced with ketamine and midazolam once the horse
was recumbent. The median induction score was excellent
in the preemptive ketamine-infused group (Table 3).
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Table 2. Horse details, surgical condition, grouping of animals into three groups. S1–6: Saline, LK1–6: low
ketamine, and HK1–6: high ketamine, n = 6 in each group.
Groups

Age (years)

Body weight (Kg)

Sex

Surgical condition

S1

5

243

M

Laceration

S2

7

300

F

Barbed wire injury

S3

8

178

F

Barbed wire injury

S4

8

430

M

Castration

S5

7

303

F

Metacarpal fracture

S6

6

250

M

Barbed wire injury

Mean ± SE

6.83 ± 0.48

284 ± 34.64

-

-

LK1

4

180

M

Tumor at scapular region

LK2

6

220

M

Barbed wire injury

LK3

7

295

M

Barbed wire injury

LK4

3

242

F

Tongue laceration

LK5

7

276

F

Tongue laceration

LK6

6

280

F

Barbed wire injury

Mean ± SE

5.5 ± 0.67

248.83 ± 17.76

-

-

HK1

3

280

M

Castration

HK2

6

193

M

Eyelid growth

HK3

3

242

F

Tongue laceration

HK4

7

383

F

Barbed wire injury

HK5

10

215

M

Extirpation of eye

HK6

6

275

M

Barbed wire injury

Mean ± SE

5.83 ± 1.08

264.67 ± 27.36

-

-

Table 3. Median ± SD of nonparametric scores and mean ± SE of down-time, thiopentone used to maintain anesthesia,
duration of surgery, first head lift, sternal recumbency, and standing time in groups S, LK, and HK. a,b,c Values with different
superscript letters differ significantly (P < 0.05) in respective parameters.

Variable

S (normal saline CRI
alone for 30 min), n = 6

LK (preemptive
ketamine @ 0.2 mg/kg
CRI for 30 min), n = 6

HK (preemptive ketamine
@ 0.4 mg/kg CRI for 30
min), n = 6

Ataxia after preemptive ketamine

1 ± 0a

2 ± 0ab

3 ± 0.41b

Quality of sedation

2.5 ± 1.21a

1 ± 0.84ab

1 ± 0b

Quality of induction

1.5 ± 0.55

1±0

1 ± 0.41

Quality of muscle relaxation

1 ± 0.52

1±0

1±0

Quality of analgesia

1±0

1±0

Post anesthetic ataxia

2 ± 0.89

3.5 ± 0.55

Quality of recovery

2 ± 0.41

2 ± 0.75

Down-time (min)

-

4.83 ± 0.31

2 ± 0.26c

Thiopentone dose (mg)

2500 ± 718.8

1750 ± 359.4

1541.67 ± 305.62

Duration of surgery (min)

77 ± 13.78

73.67 ± 9.92

49.5 ± 6.96

Time to first head lift (min)

29.83 ± 5.13

27.67 ± 3.54

23.67 ± 5.81

Time to sternal recumbency(min)

61 ± 11.53

52.5 ± 7.27

39 ± 5.6

Standing time (min)

76.33 ± 12.09

64 ± 9.29

44.17 ± 3.45

a

1±0
4 ± 0.52b

b

2 ± 0.41
b
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However, there was no significant difference (P > 0.05)
in the quality of induction between the groups. Although
a significant difference in quality of induction was not
observed, 11 out of 12 preemptive ketamine-infused
horses attained smooth induction compared to horses
anesthetized without preemptive ketamine (3/6). HR and
RR decreased significantly (P < 0.05) during induction
in all three groups (Figure 1) without any intergroup
differences (P > 0.05). There was no significant difference
(P > 0.05) in MABP during induction between groups.
3.3. Maintenance of anesthesia
Anesthesia was maintained with i.v. CRIs of ketamine
and thiopental bolus alone. All the horses received a
perioperative crystalloid solution. No additional drugs and/
or volatile agents were used for maintenance of anesthesia.
Mucous membrane was pale pink in all horses. There was

no significant difference (P > 0.05) in values of HR, RR,
MABP, and SPO2 between groups. The fluctuations in HR,
RR, MABP, and SPO2 during maintenance of anesthesia
were less evident in group HK compared to groups S and
LK (Figures 1 and 2). Quality of muscle relaxation (scores
1 and 2) and quality of analgesia (score 1) were excellent
in all groups during the perioperative period without any
significant differences (P > 0.05). Preemptive infusion
of ketamine prior to premedication did not significantly
affect any results related to maintenance of anesthesia (P
> 0.05). There was no significant difference (P > 0.05) in
the amount of thiopental (mg) used to maintain anesthesia
between groups. Also, there was no significant difference
(P > 0.05) in the duration of surgery between groups (Table
3). RT decreased significantly (P < 0.05) at 60 min in all the
groups (Figure 1).

Figure 1. Mean ± SE values of heart rate (A), respiration rate (B), and rectal temperature (RT) in groups S (normal saline CRI), LK
(ketamine at 0.2 mg/kg bwt CRI), and HK (ketamine at 0.4 mg/kg bwt CRI) at different intervals [pre (before administration of any
drug), 0 (induction), 30, 60, 120, and 180 min], n = 6.

Figure 2. Mean ± SE values of mean arterial blood pressure (A) and oxygen saturation of hemoglobin (B) in groups S (normal saline
CRI), LK (ketamine at 0.2 mg/kg bwt CRI), and HK (ketamine at 0.4 mg/kg bwt CRI) at different intervals [0 (induction), 30, and 60
min], n = 6.
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3.4. Postoperative period and recovery
There was no significant difference (P > 0.05) in the
time taken for first head lift, time to sternal recumbency,
standing time, or quality of recovery between groups. The
time taken for the first head lift was nearly 30 min for
all horses. The time to sternal recumbency and standing
time in group S took longer, followed by groups LK and
HK. All the horses stood in less than 2 h after the end of
surgery with noticeably good recovery scores of 2 ± 0.41, 2
± 0.75, and 2 ± 0.41 in groups S, LK, and HK, respectively.
In group HK, all the horses stood in less than 1 h,
although postanesthetic ataxia was significantly higher (P
< 0.05) compared to group S (Table 3). Dose-dependent
significance (P > 0.05) in postanesthetic ataxia was also not
observed. HR and RR remained within normal limits in all
groups during the postoperative period (Figure 1). There
was a significant (P < 0.05) reduction in RT from base
values 1 h after the end of surgery in all groups (Figure 1).
3.5. Hematological and serum biochemical observations
There was no specific pattern of change or clinical
significance in hematological and serum biochemical
parameters in all three groups throughout the observation
period except for values of glucose (Table 4). Glucose
increased clinically in all three groups throughout the
perioperative period and was significantly higher (P <
0.05) from the base values in group S at 30 and 60 min and
also from the other two groups (Table 4; Figure 3). The
insulin, cortisol, and IL-6 values fluctuated near the base
values in all groups throughout the study (Table 4). The
base values of IL-6 in group S were significantly (P < 0.05)
higher among and between groups.
3.6. Overall pain score
The overall pain score increased clinically at 120 min after
induction from the base value and decreased towards
base values at 180 min in all groups (Figure 4). Although
statistically insignificant (P > 0.05), the fluctuation in
postoperative pain scores at 1 h and 2 h after the end of
surgery was minimal in the HK group. All the horses were
clinically and physiologically stable without any sedation
or ataxia before 2 h after surgery. Additional NSAIDs were
given to all horses after 2 h postoperatively.
3.7. Adverse effects
No animals had any adverse effects or suffered any
significant perioperative or postoperative morbidity or
mortality. Mild box walking was noticed in a few horses
of all three groups, which was controlled by normal head
restraint.
4. Discussion
The aim of this study was to investigate the effects of
preemptive ketamine infusion given prior to premedication
in horses subjected to a conventional anesthetic protocol.
The hypotheses that preemptive ketamine infusion would

enhance sedation and reduce down-time were supported.
Although statistically insignificant, clinically, preemptive
ketamine infusion in horses at 0.4 mg/kg bwt enabled
smooth anesthetic induction, anesthetic maintenance with
minimum fluctuations in physiological variables and vital
functions, and reduced postoperative pain.
The horses were randomly divided into groups
irrespective of body weight, age, and the procedure for
which they were admitted to the clinic. The drugs used for
anesthesia, other than the test drug, were kept the same for
all horses in order to maintain uniformity among groups,
reduce bias, and retain normal clinical settings. Ketamine
was used as the sole induction agent along with midazolam,
representing its recent wide acceptance for this purpose in
horses (21,22). To minimize the use of additional drugs for
maintenance of anesthesia and thereby reduce the possible
variations and interactions on the effect of the test drug, a
TIVA protocol was chosen. TIVA is less stressful to horses
and has fewer perioperative fatalities than anesthetic
maintenance with volatile agents for surgical procedures
of less than 90 min in duration (23). Isoflurane is routinely
used in our clinics for maintenance of anesthesia, but we
used ketamine CRI at 2 mg/kg/h along with bolus doses of
thiopental whenever necessary. The CRI of i.v. ketamine at
2 mg/kg/h is routinely used as a maintenance anesthetic in
properly sedated and anesthetized horses as it retains stable
cardiovascular function (3,4). In order to minimize inhalant
anesthetic requirements and the potential hazards such as
hypotension and respiratory depression associated with the
use of inhalant anesthetics, it is often necessary to administer
additional drugs and supplementary anesthetics (22). For
the above reasons, and considering the short to medium
duration of the surgical procedures performed, volatile
agents were not used for maintenance of anesthesia. The
i.v. administration of thiopental to properly premedicated
normal healthy horse produces only mild hemodynamic
changes (24). Moreover, the hazards associated with bolus
dosing of thiopental were not encountered in any of the
horses when maintained along with CRI of ketamine. The
cardiopulmonary and physiological variables reflected
the expected outcome during maintenance of anesthesia,
shown by no significant differences between variables
in all the groups and minimum fluctuation in the high
preemptive ketamine-infused group. It is recognized that
CRI of ketamine has no substantial effects on the respiratory
system (8). Significant bradycardia and decreased MABP
were detected 6 h after ketamine CRI in a previous study
(8). The CRI of ketamine used in our study for short- to
medium-term infusion did not show any such significant
cardiovascular depressing effects. Whenever a surgical
procedure exceeded or tended to exceed considerably
more than 60–90 min, the horses were shifted to inhalant
anesthesia and were excluded from the study.
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IL-6
(pg/dL)

Cortisol
(ng/dL)

Insulin
(pg/dL)

Glucose
(mg/dL)

Groups

Variables

Table 4. Mean ± SE of glucose, insulin, cortisol, and IL-6 values in groups S (normal saline CRI), LK (ketamine
at 0.2 mg/kg bwt CRI), and HK (ketamine at 0.4 mg/kg bwt CRI for 30 min and 30 min before preanesthetics
were given), n = 6. a,b,c,α,β,γ Values with different superscript letters differ significantly (P < 0.05) in corresponding
intervals in respective parameters.
Interval (min)
Base value

0

30

60

120

180

S

153.83
± 29.07bcd

154.83
± 34.77bcd

227.83
± 35.73aα

222
± 34.75aα

193.83
± 27.95abc

205.67
± 24.99ab

LK

131.17
± 17.36d

140.2
± 16.85cd

155.53
± 23.37bcdβ

146.83
± 23.83cdβ

149.5
± 22.56cd

145.93
± 14.22cd

HK

112.67
± 11.95d

114.17
± 10.24d

153
± 15.04bcdγ

144.5
± 13.24cdγ

153.67
± 10.17bcd

149.33
± 16.62cd

S

7.47
± 0.98a

7.06
± 0.66ab

6.4
± 1.03abcd

6.4
± 0.85abcd

6.45
± 0.96abcd

6.67
± 1.06abc

LK

3.43
± 1.33f

3.61
± 1.26f

3.14
± 1.28f

3.86
± 1.25ef

3.6
± 1.43f

3.64
± 1.38f

HK

5.35
± 1.53cd

5.11
± 1.47de

5.31
± 1.48d

5.77
± 1.71bcd

5.68
± 1.67cd

5.11
± 1.92de

S

56.9
± 11.2a

49.38
± 9.7a

47.25
± 11.04a

47
± 8.62a

45.12
± 8.63a

54.54
± 9.29a

LK

46.22
± 32.46a

71.87
± 56.72a

94.52
± 81.64a

27.82
± 13.2a

34.02
± 18.87a

62.4
± 46.18a

HK

48.79
± 25.83a

48.85
± 25.88a

45.84
± 26.22a

36.84
± 21.45a

31.34
± 17.51a

31.63
± 18.02a

S

373.54
± 129.37a

199.52
± 30.2b

239.76
± 38.39ab

224.68
± 47.29ab

224.6
± 52.94ab

145.37
± 37.23b

LK

110.27
± 28.59b

119.65
± 32.23b

125.54
± 36.08b

115.35
± 19.69b

127.41
± 26.69b

138.21
± 32.74b

HK

176.45
± 52.64b

159.3
± 47.37b

150.56
± 43.77b

159.85
± 49.51b

133.38
± 30.41b

144.71
± 28.47b

A wide range of surgical procedures performed in
equine clinical practice were included in this study. The pain
inflicted by these procedures may vary from mild to severe.
Quality of analgesia during the procedure was scored as
excellent in all the horses because of the adequacy of pain
control. Although contradictory reports on analgesic effects
of ketamine at subanesthetic doses in normal awake horses
exist (8), in horses suffering from pain, inflammatory tissue
injury, and/or endotoxemia, ketamine at subanesthetic
doses has been documented to possess analgesic and
antiinflammatory activity (11). Our deliberation was on
whether infusion of a subanesthetic dose of ketamine as a
preemptive analgesic before the initial surgical stimulus
prevented the establishment of an altered processing of pain
stimuli during surgery and in the immediate postoperative
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period. Postoperative pain scores were excellent in all horses,
irrespective of group, 2 h after surgery. The hypothesized
analgesic effect of preemptive ketamine infusion in reducing
postoperative pain could not be evaluated meticulously
because of possible cumulative interference of the effects
of preoperative butorphanol, xylazine, and ketamine and
perioperative CRI of ketamine. Evidence suggests that
butorphanol may be efficacious for treatment of visceral
pain in horses and possesses minimum effects in sharp
superficial and deep somatic pain (25,26). Preemptive
and/or perioperative ketamine infusion is thought to have
mitigated the perioperative and postoperative superficial
and deep somatic pain caused by surgical procedures. The
adverse effects were also less, unlike opioids with anticipated
reduction in propulsive gastrointestinal motility (27).
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Figure 3. Mean ± SE values of glucose in groups S (normal
saline CRI), LK (ketamine at 0.2 mg/kg bwt CRI), and HK
(ketamine at 0.4 mg/kg bwt CRI) at different intervals [pre
(before administration of any drug), 0 (induction), 30, 60, 120,
and 180 min], n = 6, *: significant (P < 0.05) change from pre
value in group S; *,α, β: significant difference (P < 0.05) between
groups at corresponding intervals.

This study was also intended to compare the effects
of preemptive ketamine infusion at two different doses,
0.2 mg/kg bwt and 0.4 mg/kg bwt, in horses usually
premedicated with xylazine and butorphanol. The dose
rates were selected based on results from previous studies
(8,9). CRI of ketamine at dose rates from 0.4 mg/kg/h to
1.5 mg/kg/h has been safely administered for prolonged
duration in healthy awake horses without any adverse
effects while higher doses, above 1.5 mg/kg/h, for a longer
period showed excitation (8). A delayed gastrointestinal
transit time was reported in horses with infusions at 1.2
mg/kg/h for more than 24 h (28). Lower doses of ketamine
were selected for preemptive infusion in order to avoid
any disturbing effects of NMDA receptor antagonism like
excitation, tremors, and ataxia. Preemptive ketamineinfused horses achieved recumbency before any induction
agents were given. This has been referred to as downtime in this study. A dose-dependent shorter down-time
was observed in preemptive ketamine-infused horses.
At higher doses of 0.4 mg/kg bwt, preemptive ketamine
further reduced down-time and the horses were adequately
sedated. Subanesthetic doses of preemptive ketamine
infusions in normal awake horses lack sedative effects, but
they effectively augment sedation at higher dose rates of
infusion when combined with xylazine and butorphanol
(6). Initiation of preanesthetic drugs 30 min after ketamine
infusion complemented the action of the preanesthetic
drugs. Heart rate decreased during induction of anesthesia
in all the horses, attributed to baroreceptor activation by the
alpha2 adrenoceptor agonist, but the variation in different
perioperative intervals was minimal in horses infused with

Figure 4. Mean ± SE values of overall pain score in groups S
(normal saline CRI), LK (ketamine at 0.2 mg/kg bwt CRI), and
HK (ketamine at 0.4 mg/kg bwt CRI) at different intervals [pre
(before administration of any drug), 1 h after the end of surgery,
and 2 h after the end of surgery], n = 6.

a high dose of preemptive ketamine. High-dose ketamine
infusion preserved the sympathetic drive and minimized
the fluctuations in cardiorespiratory parameters caused by
xylazine compared to low preemptive ketamine infusion.
Ketamine induction and perioperative ketamine CRI
appeared to obliterate any potential dose-dependent
anesthetic sparing effects of preemptive ketamine infusion.
Shifting of weight and dose-dependent ataxia was evident
during the lag period in horses infused with preemptive
ketamine at 0.4 mg/kg bwt. Upon standing postoperatively,
the preemptive ketamine-infused horses were significantly
more ataxic.
The fluctuation in postoperative pain scores at 1 h and
2 h after the end of surgery was considerably less in horses
infused with preemptive ketamine at 0.4 mg/kg bwt.
Owing to the small number of horses in each group and
the small difference in the range of doses of preemptive
ketamine chosen for evaluation, it was difficult to reach a
dose-dependent conclusive result on postoperative pain.
Further investigation is hence warranted at higher dose
rates as preemptive infusion. As CRI of ketamine was
given to all horses perioperatively, ataxia and decline in
rise of postoperative pain may have been expected to occur
in almost equal ranges of scores among all three groups.
However, insignificant variations were noticed between
groups. A triggering effect of preemptive ketamine in
inhibiting altered pain processing or an additive effect
along with perioperative ketamine is hence thought to
have occurred in the horses. A better understanding of the
dynamic action of preemptive ketamine may be obtained if
the plasma drug concentration is measured and compared
with clinical effects. An initial distributive phase of nearly
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2.3 min followed by slow elimination with a half-life of
67.4 min has been estimated for CRI of ketamine at 1.5
mg/kg/h in healthy awake horses (9). During infusion of
ketamine at 0.4 mg/kg/h for 6 h in a study, the half-life
of disappearance estimated was 2.16 h (8). The clearance
and half-life of ketamine are faster in normal awake
animals than those sedated and anesthetized (29,30).
The elimination of ketamine from circulation is hence
thought to have been decreased by the low infusion rates
of preemptive ketamine, and it may be further delayed
by sedatives and anesthetics. The perioperative CRI of
ketamine might have compensated the likely fall in plasma
concentration of preemptively infused ketamine over
time. This might have been reflected in the perioperative
and immediate postoperative effects in horses infused with
preemptive ketamine. We did not measure the ketamine in
the blood following preemptive infusion or postoperatively,
but shifting of weight and ataxia in preemptive ketamineinfused horses alone substantiated the effect of ketamine.
The hematological and serum biochemical parameters
invariably remained the same throughout the study in all
groups. In horses anesthetized without preemptive ketamine
infusion, a significantly high rise in glucose during the
perioperative period was observed. Alpha2 adrenoceptor
agonists induce hyperglycemia by inhibiting insulin release
(31), but the profound hyperglycemia noticed only in
horses anesthetized without preemptive ketamine showed
an apparent surgical stress-induced hyperglycemia due to
gluconeogenesis. Infusion of preemptive ketamine did not
show any effect on serum insulin and cortisol levels. In
normal awake horses, ketamine increases catecholamines
and raises the circulating plasma cortisol because of its
sympathomimetic effects (9). Rather than as CRI alone,
ketamine when used along with sedatives and anesthetics
has been shown to delay the rise in cortisol level and
mitigate the stress response (10). The preoperative and/or
perioperative CRI of ketamine is hence thought to have
facilitated amelioration of the stress response to surgery.
The high base value of IL-6, a major factor in acute
phase immune responses, in group S may correspond to
the inherent inflammatory changes due to the surgical
condition of horses in this group. The members of the
IL-6 family have proinflammatory effects in addition to

antiinflammatory effects such as downregulation of the
inflammatory cascade by inhibiting TNF-alpha synthesis
(32). The preemptive and/or perioperative infusion of
ketamine maintained IL-6 base values throughout the
study. Further investigation may be necessary from a
broad perspective to assess their roles in contending with
inflammation during ketamine administration.
No adverse effects or postoperative morbidity were
observed in any of the horses enrolled in the study except
for mild box walking, which is consistently reported in
horses premedicated with butorphanol (22). The locomotor
activity after elective surgeries under i.v. anesthesia was
noticed in ponies premedicated with opioids (33).
In conclusion, preemptive ketamine infusion prior
to premedication in horses at 0.4 mg/kg bwt enhances
quality of sedation and shortens the down-time. Although
statistical significance was not observed, clinically,
preemptive ketamine infusion in horses at 0.4 mg/kg bwt
enabled smooth anesthetic induction with minimum
fluctuations in perioperative physiological and vital
functions and reduced postoperative pain. More clinical
studies to investigate the effects of subanesthetic doses
of preemptive ketamine in a larger population may be
warranted prior to routine use in anesthetic practice.
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